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Background
During the last decades Chinese Hamster Ovary (CHO)
cells have been extensively used for research and biotech-
nological applications. About 40% of newly approved gly-
cosylated protein pharmaceuticals are produced in CHO
cells today [1]. Despite the increasing relevance of these
cells for biopharmaceutical production little is known
about effects of intracellular processes on productivity
and product quality.
In the last years supplementation of serum-free media
with insulin - more and more replaced by IGF-1 and its
analogue LongR3 - was utilized to enhance product titer
and quality. To compare the intracellular effects of these
two supplements an antibody producing CHO cell line
was cultivated in batch mode using insulin, LongR3 or
no growth factor as reference. Subsequently, different
omics-techniques were applied to analyze medium and
cell samples.
Materials and methods
CHO cells producing an antibody were cultured in chemi-
cally defined serum-free medium TC-BN.CHO (Teutocell
AG) with addition of 6 mM glutamine. Three cultivations
(37°C, pH 7.1, 40% DO, 120 rpm) were performed in
2l-bioreactor systems with supplementation of 10 mg/l
insulin or 0.1 mg/l LongR3. The third culture was
untreated and served as reference. Samples were taken
every 24 h.
Viable cell density and cell viability were measured
using Cedex (Roche). Glucose and lactate were deter-
mined via YSI 2300 STAT Plus™ Glucose & Lactate
Analyzer (YSI Life Science). Quantitation of antibody
production was determined using POROS® A columns
(Invitrogen). N-Glycan abundance was analyzed by
HPAEC-PAD method [2].
For RNA samples ‘Total RNA NucleoSpin Kit’
(Macherey-Nagel) was used. Quality and quantity of
RNA were determined using Nano Drop 1000 (Peqlab)
and Bioanalyzer (Agilent).
An in-house developed customized cDNA microarray
with 41,304 probes was applied for transcriptome analysis.
RNA was labeled using Agilent LIQUA Kit, one-color.
Processing of microarray data was performed in Array-
Lims and EMMA2 [3]. Raw data were standardized using
Feature Extractor (Agilent) and LOWESS normalization.
Results
Cultivation data illustrated that maximal cell density was
higher in cultivations with insulin and LongR3 compared
to that without growth factor. Additionally, glucose con-
sumption and lactate production was slightly higher in
cultivations with these supplements but time point of
glutamine depletion was similar in all reactors after
similar cultivation time (Figure 1A). Furthermore, pro-
duct quantity and product quality was not influenced by
growth factor addition. The most abundant glycoforms
after 7 days of cultivation were G0F with about 50% and
G1F with about 40% in all cultivation set-ups (Table 1).
For transcriptome analysis samples on day 5 were
compared with those on day 3. Therefore, the following
settings were used in statistical tests: a two-sample t-test
with a p-value ≤ 0.01, signal intensity ≥ 6 (for A1 or A2)
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and intensity ratio ≥ 0.6 or ≤ -0.6 (for M1 or M2). Tran-
scriptome data showed that LongR3 supplementation
resulted in the highest transcription change (1259 up-
and 1689 down-regulated). Insulin supplementation
resulted in second highest transcriptomic change (1026
up- and 1404 down-regulated) and reference cultivation
led to lowest changes (344 up- and 301down-regulated).
Supplemented cultures showed a higher transcription
change in the selected pathways, like pentose phosphate
pathway, TCA and glycolysis, than the reference culture,
too. In LongR3 containing cultures even more genes
from these pathways were higher changed (Figure 1B).
Conclusions
Data on cell growth and productivity as well as omics
results were brought together to achieve a deeper
insight into cellular processes and their influence on
productivity and product quality.
Cultivation data showed faster growth, glucose con-
sumption and lactate formation for cultivations with
insulin and LongR3 compared to reference culture.
However, antibody titer and glycan profiles were almost
similar in all cultures. This indicates that supplementa-
tion with insulin or LongR3 does not have an enhancing
effect on product quality and quantity in antibody pro-
duction with our CHO-K1 cells.
Additionally, transcriptome data showed that growth
factor supplementation resulted in a higher transcription
change than in reference cultivation. Thus, for more
understanding of the influence of insulin or LongR3 sup-
plementation on cultured CHO cells, further analysis of
pathway regulation with full details is required.
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Figure 1 (A) Time chart of viable cell density (VCD), cell viability (CV) and extracellular metabolites [glucose (Glc), lactate (Lac), glutamine (Gln)].
(B) Number of significantly up- and down-regulated genes on day 5 in selected pathways (compared to day 3).
Table 1 N-Glycan abundance [%] after 7 days of
cultivation.
Culture G0F G0 G1F G1 G2F G2
Reference 51,8 4,1 35,6 0,9 7,4 0,2
Insulin 50,6 3,4 38,6 0,9 6,3 0,2
LongR3 52,5 1,4 38,5 0,5 6,9 0,3
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